Detection and activation of human Vα24+ natural killer T cells using α-galactosyl ceramide-pulsed dendritic cells

Journal of Immunological Methods

Volumn 272, Issue 1-2, 2003, Pages 147-159

  Fujii, Shin ichiro ^a   Shimizu, Kanako ^a   Steinman, Ralph M ^a   Dhodapkar, Madhav V ^a,b  

^a ROCKEFELLER UNIVERSITY   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Galactosylceramide; Dendritic cells; Enzyme linked immunospot; IL 4; Immunotherapy; Interferon ; NKT cells

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; CD1D ANTIGEN; GALACTOSYLCERAMIDE; GAMMA INTERFERON; INTERLEUKIN 4; UNCLASSIFIED DRUG;

ANTIGEN PRESENTING CELL; ARTICLE; ASSAY; BLOOD; CELL ACTIVATION; CELL CULTURE; CELL FUNCTION; CELL ISOLATION; CELL LINE; CELL MATURATION; CELL TYPE; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; ENZYME LINKED IMMUNOSPOT ASSAY; EVALUATION; HUMAN; HUMAN CELL; MACROPHAGE; MONOCYTE; NATURAL KILLER CELL; NORMAL HUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TH1 CELL;

ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE; CELL DIFFERENTIATION; CELL LINE; DENDRITIC CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GALACTOSYLCERAMIDES; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; IMMUNOLOGIC TECHNIQUES; IMMUNOTHERAPY; INTERFERON TYPE II; INTERLEUKIN-4; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MACROPHAGES; MONOCYTES; T-LYMPHOCYTE SUBSETS;

EID: 0037437909     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-1759(02)00497-0     Document Type: Article

References (45)

1. Apostolou I., Takahama Y., Belmant C., Kawano T., Huerre M., Marchal G., Cui J., Taniguchi M., Nakauchi H., Fournie J.J., Kourilsky P., Gachelin G. Murine natural killer T(NKT) cells contribute to the granulomatous reaction caused by mycobacterial cell walls. Proc. Natl. Acad. Sci. U. S. A. 96:1999;5141-5146.
2. Banchereau J., Briere F., Caux C., Davoust J., Lebecque S., Liu Y.J., Pulendran B., Palucka K. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18:2000;767-811.
3. Banchereau J., Schuler-Thurner B., Palucka A.K., Schuler G. Dendritic cells as vectors for therapy. Cell. 106:2001;271-274.
4. Bendelac A., Rivera M.N., Park S.H., Roark J.H. Mouse CD1-specific NK1 T cells: development, specificity, and function. Annu. Rev. Immunol. 15:1997;535-562.
5. Benlagha K., Bendelac A. CD1d-restricted mouse V alpha 14 and human V alpha 24 T cells: lymphocytes of innate immunity. Semin. Immunol. 12:2000;537-542.
6. Benlagha K., Weiss A., Beavis A., Teyton L., Bendelac A. In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers. J. Exp. Med. 191:2000;1895-1903.
7. Burdin N., Brossay L., Kronenberg M. Immunization with alpha-galactosylceramide polarizes CD1-reactive NK T cells towards Th2 cytokine synthesis. Eur. J. Immunol. 29:1999;2014-2025.
8. Carnaud C., Lee D., Donnars O., Park S.H., Beavis A., Koezuka Y., Bendelac A. Cutting edge: cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells. J. Immunol. 163:1999;4647-4650.
9. Chen H., Paul W.E. Cultured NK1.1+ CD4+ T cells produce large amounts of IL-4 and IFN-gamma upon activation by anti-CD3 or CD1. J. Immunol. 159:1997;2240-2249.
10. Dellabona P., Casorati G., Friedli B., Angman L., Sallusto F., Tunnacliffe A., Roosneek E., Lanzavecchia A. In vivo persistence of expanded clones specific for bacterial antigens within the human T cell receptor alpha/beta CD4-8- subset. J. Exp. Med. 1993;1763-1771.
11. Dhodapkar M.V., Steinman R.M., Sapp M., Desai H., Fossella C., Krasovsky J., Donahoe S.M., Dunbar P.R., Cerundolo V., Nixon D.F., Bhardwaj N. Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells. J. Clin. Invest. 104:1999;173-180.
12. Dhodapkar M.V., Steinman R.M., Krasovsky J., Munz C., Bhardwaj N. Antigen specific inhibition of effector T cell function in humans after injection of immature dendritic cells. J. Exp. Med. 193:2001;233-238.
13. Exley M., Garcia J., Balk S.P., Porcelli S. Requirements for CD1d recognition by human invariant Valpha24+ CD4-CD8- T cells. J. Exp. Med. 186:1997;109-120.
14. Exley M., Garcia J., Wilson S.B., Spada F., Gerdes D., Tahir S.M., Patton K.T., Blumberg R.S., Porcelli S., Chott A., Balk S.P. CD1d structure and regulation on human thymocytes, peripheral blood T cells, B cells and monocytes. Immunology. 100:2000;37-47.
15. Fujii S., Shimuzu K., Kronenberg M., Steinman R.M. Prolonged interferon-g producing NKT responses induced with a-galactosyl ceramide loaded dendritic cells. Nat. Immunol. 3:2002;867-874.
16. Godfrey D.I., Hammond K.J., Poulton L.D., Smyth M.J., Baxter A.G. NKT cells: facts, functions and fallacies. Immunol. Today. 21:2000;573-583.
17. Gonzalez-Aseguinolaza G., de Oliveira C., Tomaska M., Hong S., Bruna-Romero O., Nakayama T., Taniguchi M., Bendelac A., Van Kaer L., Koezuka Y., Tsuji M. Alpha-galactosylceramide-activated Valpha 14 natural killer T cells mediate protection against murine malaria. Proc. Natl. Acad. Sci. U. S. A. 97:2000;8461-8466.
18. Gumperz J.E., Miyake S., Yamamura T., Brenner M.B. Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining. J. Exp. Med. 195:2002;625-636.
19. Hong S., Wilson M.T., Serizawa I., Wu L., Singh N., Naidenko O.V., Miura T., Haba T., Scherer D.C., Wei J., Kronenberg M., Koezuka Y., Van Kaer L. The natural killer T-cell ligand alpha-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice. Nat. Med. 7:2001;1052-1056.
20. Ikarashi Y., Mikami R., Bendelac A., Terme M., Chaput N., Terada M., Tursz T., Angevin E., Lemonnier F.A., Wakasugi H., Zitvogel L. Dendritic cell maturation overrules H-2D-mediated natural killer T (NKT) cell inhibition: critical role for B7 in CD1d-dependent NKT cell interferon gamma production. J. Exp. Med. 194:2001;1179-1186.
21. Jonuleit H., Kuhn U., Muller G., Steinbrink K., Paragnik L., Schmitt E., Knop J., Enk A.H. Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur. J. Immunol. 27:1997;3135-3142.
22. Karadimitris A., Gadola S., Altamirano M., Brown D., Woolfson A., Klenerman P., Chen J.L., Koezuka Y., Roberts I.A., Price D.A., Dusheiko G., Milstein C., Fersht A., Luzzatto L., Cerundolo V. Human CD1d-glycolipid tetramers generated by in vitro oxidative refolding chromatography. Proc. Natl. Acad. Sci. U. S. A. 98:2001;3294-3298.
23. Kawano T., Cui J., Koezuka Y., Toura I., Kaneko Y., Motoki K., Ueno H., Nakagawa R., Sato H., Kondo E., Koseki H., Taniguchi M. CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides. Science. 278:1997;1626-1629.
24. Kawano T., Cui J., Koezuka Y., Toura I., Kaneko Y., Sato H., Kondo E., Harada M., Koseki H., Nakayama T., Tanaka Y., Taniguchi M. Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Valpha14 NKT cells. Proc. Natl. Acad. Sci. U. S. A. 95:1998;5690-5693.
25. Kawano T., Nakayama T., Kamada N., Kaneko Y., Harada M., Ogura N., Akutsu Y., Motohashi S., Iizasa T., Endo H., Fujisawa T., Shinkai H., Taniguchi M. Antitumor cytotoxicity mediated by ligand-activated human V alpha24 NKT cells. Cancer Res. 59:1999;5102-5105.
26. Kojo S., Adachi Y., Keino H., Taniguchi M., Sumida T. Dysfunction of T cell receptor AV24AJ18+, BV11+ double-negative regulatory natural killer T cells in autoimmune diseases. Arthritis Rheum. 44:2001;1127-1138.
27. Langenkamp A., Messi M., Lanzavecchia A., Sallusto F. Kinetics of dendritic cell activation: impact on priming of TH1, TH2 and nonpolarized T cells. Nat. Immunol. 1:2000;311-316.
28. Lee P.T., Benlagha K., Teyton L., Bendelac A. Distinct functional lineages of human V(alpha)24 natural killer T cells. J. Exp. Med. 195:2002;637-641.
29. Matsuda J.L., Naidenko O.V., Gapin L., Nakayama T., Taniguchi M., Wang C.R., Koezuka Y., Kronenberg M. Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers. J. Exp. Med. 192:2000;741-754.
30. Metelitsa L.S., Naidenko O.V., Kant A., Wu H.W., Loza M.J., Perussia B., Kronenberg M., Seeger R.C. Human NKT cells mediate antitumor cytotoxicity directly by recognizing target cell CD1d with bound ligand or indirectly by producing IL-2 to activate NK cells. J. Immunol. 167:2001;3114-3122.
31. Nakagawa R., Motoki K., Ueno H., Iijima R., Nakamura H., Kobayashi E., Shimosaka A., Koezuka Y. Treatment of hepatic metastasis of the colon26 adenocarcinoma with an alpha-galactosylceramide, KRN7000. Cancer Res. 58:1998;1202-1207.
32. Nieda M., Nicol A., Koezuka Y., Kikuchi A., Takahashi T., Nakamura H., Furukawa H., Yabe T., Ishikawa Y., Tadokoro K., Juji T. Activation of human Valpha24NKT cells by alpha-glycosylceramide in a CD1d-restricted and Valpha24TCR-mediated manner. Hum. Immunol. 60:1999;10-19.
33. Nishi N., van der Vliet H.J., Koezuka Y., von Blomberg B.M., Scheper R.J., Pinedo H.M., Giaccone G. Synergistic effect of KRN7000 with interleukin-15, -7, and -2 on the expansion of human V alpha 24+V beta 11+ T cells in vitro. Hum. Immunol. 61:2000;357-365.
34. Park S.H., Bendelac A. CD1-restricted T-cell responses and microbial infection. Nature. 406:2000;788-792.
35. Porcelli S., Yockey C.E., Brenner M.B., Balk S.P. Analysis of T cell antigen receptor (TCR) expression by human peripheral blood CD4-8- alpha/beta T cells demonstrates preferential use of several V beta genes and an invariant TCR alpha chain. J. Exp. Med. 178:1993;1-16.
36. Sharif S., Arreaza G.A., Zucker P., Mi Q.S., Sondhi J., Naidenko O.V., Kronenberg M., Koezuka Y., Delovitch T.L., Gombert J.M., Leite-De-Moraes M., Gouarin C., Zhu R., Hameg A., Nakayama T., Taniguchi M., Lepault F., Lehuen A., Bach J.F., Herbelin A. Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes. Nat. Med. 7:2001;1057-1062.
37. Shin T., Nakayama T., Akutsu Y., Motohashi S., Shibata Y., Harada M., Kamada N., Shimizu C., Shimizu E., Saito T., Ochiai T., Taniguchi M. Inhibition of tumor metastasis by adoptive transfer of IL-12-activated Valpha14 NKT cells. Int. J. Cancer. 91:2001;523-528.
38. Smyth M.J., Crowe N.Y., Pellicci D.G., Kyparissoudis K., Kelly J.M., Takeda K., Yagita H., Godfrey D.I. Sequential production of interferon-gamma by NK1.1(+) T cells and natural killer cells is essential for the antimetastatic effect of alpha-galactosylceramide. Blood. 99:2002;1259-1266.
39. Spada F.M., Koezuka Y., Porcelli S.A. CD1d-restricted recognition of synthetic glycolipid antigens by human natural killer T cells. J. Exp. Med. 188:1998;1529-1534.
40. Spada F.M., Borriello F., Sugita M., Watts G.F., Koezuka Y., Porcelli S.A. Low expression level but potent antigen presenting function of CD1d on monocyte lineage cells. Eur. J. Immunol. 30:2000;3468-3477.
41. Steinman R., Dhodapkar M. Active immunization against cancer with dendritic cells: the near future. Int. J. Cancer. 94:2001;459-473.
42. Takahashi T., Chiba S., Nieda M., Azuma T., Ishihara S., Shibata Y., Juji T., Hirai H. Cutting edge: analysis of human V alpha 24+CD8+ NK T cells activated by alpha-galactosylceramide-pulsed monocyte-derived dendritic cells. J. Immunol. 168:2002;3140-3144.
43. Toura I., Kawano T., Akutsu Y., Nakayama T., Ochiai T., Taniguchi M. Cutting edge: inhibition of experimental tumor metastasis by dendritic cells pulsed with alpha-galactosylceramide. J. Immunol. 163:1999;2387-2391.
44. van der Vliet H.J., Nishi N., Koezuka Y., von Blomberg B.M., van den Eertwegh A.J., Porcelli S.A., Pinedo H.M., Scheper R.J., Giaccone G. Potent expansion of human natural killer T cells using alpha-galactosylceramide (KRN7000)-loaded monocyte-derived dendritic cells, cultured in the presence of IL-7 and IL-15. J. Immunol. Methods. 247:2001;61-72.
45. Wilson S.B., Kent S.C., Patton K.T., Orban T., Jackson R.A., Exley M., Porcelli S., Schatz D.A., Atkinson M.A., Balk S.P., Strominger J.L., Hafler D.A. Extreme TH1 bias of invariant Vα24JαQ T cells in type 1 diabetes. Nature. 391:1998;177-181.